It was also pointed out that the government is delaying the preparation of a sub-law of a clause that favors the price of new drugs developed by innovative pharmaceutical companies in the Special Act on the Promotion of the Pharmaceutical Industry. Critics say that it has not been active in subsequent legislation such as enforcement ordinances and enforcement rules for the fourth year of legislation.

On the 5th, Rep. Nam In-soon of the Democratic Party of Korea claimed, "We need to come up with a policy of preferential treatment for new drugs made by innovative pharmaceutical companies as soon as possible." Nam is criticizing the government for being indifferent to follow-up legislation even though the